Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy | Zendy

Kapuczinski Abeline | Zendy; Cotils Michel | Zendy; Gombeir Yannick | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy

Author(s) -

Kapuczinski Abeline,

Cotils Michel,

Gombeir Yannick

Publication year - 2021

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.4180

Subject(s) - rituximab , medicine , interstitial pneumonia , pneumonia , salvage therapy , intensive care medicine , covid-19 , usual interstitial pneumonia , lung , immunology , pathology , disease , lymphoma , infectious disease (medical specialty) , chemotherapy

Interstitial pneumonia with autoimmune features is a complex and heterogeneous research classification without clear management and should be discussed on a case‐by‐case basis in a pluridisciplinary way. Rituximab could be used for severe lung involvement. The coronavirus crisis can hide other pathologies in such a way that a diagnosis can be overlooked.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research